These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15913)

  • 41. From biochemical to biophysical placental function tests in fetal surveillance.
    Arabin B; Ragosch V; Mohnhaupt A
    Am J Perinatol; 1995 May; 12(3):168-71. PubMed ID: 7612087
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Surveillance of pregnancies with placental dysfunction. IV. Significance of biochemical placental values].
    Schmid J
    Z Geburtshilfe Perinatol; 1976 Feb; 180(1):21-4. PubMed ID: 1266271
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estriol in saliva as an index of fetoplacental function.
    Huang NH; Besch NF; Hays BM; Hinkley CM; Besch PK
    Am J Obstet Gynecol; 1983 Jun; 146(3):336-8. PubMed ID: 6859148
    [No Abstract]   [Full Text] [Related]  

  • 44. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fetal death in utero: effect on estrone, estradiol-17 beta and progesterone levels in the ewe.
    Abrams RM; Kalra PS; Clapp JF; Wilcox CJ; Carter RL
    Gynecol Obstet Invest; 1982; 13(3):177-83. PubMed ID: 7095597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical thinking in modern obstetrics. II. The hormonal and cardiotocographic aspects].
    Katsurov A
    Akush Ginekol (Sofiia); 1985; 24(2):1-8. PubMed ID: 3893188
    [No Abstract]   [Full Text] [Related]  

  • 47. Plasma estrogen response to dehydroepiandrosterone sulphate injection in normal and complicated late pregnancy.
    Fraser IS; Leask R; Drife J; Bacon L; Michie E
    Obstet Gynecol; 1976 Feb; 47(2):152-8. PubMed ID: 129714
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of endogenous steroid levels with high and low density lipoprotein concentrations in the human maternal-fetoplacental unit at term.
    Nayar S; Reggio BC; Henson MC
    J Reprod Med; 1996 Feb; 41(2):91-8. PubMed ID: 8656421
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of placental function in uncomplicated and complicated late pregnancy by estimation of unconjugated oestrogens in plasma after an intravenous injection of dehydroepiandrosterone sulphate.
    Axelsson O; Nilsson BA; Johansson ED
    Acta Endocrinol (Copenh); 1978 Oct; 89(2):359-71. PubMed ID: 151472
    [No Abstract]   [Full Text] [Related]  

  • 50. Placental pulsatility index: a new, more sensitive parameter for predicting adverse outcome in pregnancies suspected of fetal growth restriction.
    Gudmundsson S; Flo K; Ghosh G; Wilsgaard T; Acharya G
    Acta Obstet Gynecol Scand; 2017 Feb; 96(2):216-222. PubMed ID: 27858967
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tests of fetal wellbeing in the third trimester of pregnancy.
    Hughes G; Bischof P; Wilson G; Smith R; Klopper A
    Br J Obstet Gynaecol; 1980 Aug; 87(8):650-6. PubMed ID: 6158994
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of prostaglandin E2 in the management of intra-uterine death.
    Scher J; Kiwi R; Baillie P
    S Afr Med J; 1974 Oct; 0(0):Suppl:41-3. PubMed ID: 4422764
    [No Abstract]   [Full Text] [Related]  

  • 53. Doppler ultrasound of the uterine artery in the prediction of severe complications during low-risk pregnancies.
    Schwarze A; Nelles I; Krapp M; Friedrich M; Schmidt W; Diedrich K; Axt-Fliedner R
    Arch Gynecol Obstet; 2005 Jan; 271(1):46-52. PubMed ID: 15185101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of estradiol administration on feto-placental growth in rat.
    Matsuura S; Itakura A; Ohno Y; Nakashima Y; Murata Y; Takeuchi M; Kobayashi M; Mizutani S
    Early Hum Dev; 2004 Apr; 77(1-2):47-56. PubMed ID: 15113631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Antenatal monitoring by pregnancy-specific beta 1 glycoprotein 125I radioimmunoassay].
    Zhang WY
    Zhonghua Fu Chan Ke Za Zhi; 1987 Nov; 22(6):329-31, 374. PubMed ID: 3502331
    [No Abstract]   [Full Text] [Related]  

  • 56. What do placental function tests predict? Observations on placental lactogen levels in growth retardation and fetal distress.
    Obiekwe BC; Chard T
    Eur J Obstet Gynecol Reprod Biol; 1982 Nov; 14(2):69-73. PubMed ID: 7173482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Transplacental fetomaternal transfusion in physiological labor and in various pathological states of pregnancy and labor].
    Jakubowska M; Sikorski R
    Ginekol Pol; 1980 Dec; 51(12):1123-8. PubMed ID: 7203124
    [No Abstract]   [Full Text] [Related]  

  • 58. [Findings on the behavior of beta 1 SP 1 in normal and complicated pregnancies].
    Guaschino S; Pesando PC; Montanari L; Bolis PF; Imbriani M
    Ann Ostet Ginecol Med Perinat; 1981; 102(2):95-9. PubMed ID: 6973308
    [No Abstract]   [Full Text] [Related]  

  • 59. [Estriol reaction test for the diagnosis of fetal distress in the 3d trimester].
    Distler W; Brand H
    Z Geburtshilfe Perinatol; 1983; 187(1):17-22. PubMed ID: 6682593
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gas-liquid chromatographic measurement of oestriol, oestrone and oestradiol-17 beta in the plasma of pregnant women. A method and its application in the second half of normal and pathological pregnancies.
    Fischer-Rasmussen W
    Dan Med Bull; 1972 Sep; 19():Suppl 2:1-56. PubMed ID: 4642919
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.